HEADER TRANSFERASE/TRANSFERASE INHIBITOR 13-FEB-17 5USQ TITLE ALK-5 KINASE INHIBITOR COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: TGF-BETA RECEPTOR TYPE-1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 123-421; COMPND 5 SYNONYM: TGFR-1,ACTIVIN A RECEPTOR TYPE II-LIKE PROTEIN KINASE OF COMPND 6 53KD,ACTIVIN RECEPTOR-LIKE KINASE 5,ALK5,SERINE/THREONINE-PROTEIN COMPND 7 KINASE RECEPTOR R4,SKR4,TGF-BETA TYPE I RECEPTOR,TRANSFORMING GROWTH COMPND 8 FACTOR-BETA RECEPTOR TYPE I,TBETAR-I; COMPND 9 EC: 2.7.11.30; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TGFBR1, ALK5, SKR4; SOURCE 6 EXPRESSION_SYSTEM: UNIDENTIFIED BACULOVIRUS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10469 KEYWDS TGF-BETA RECEPTOR TYPE I, SERINE/THREONINE-PROTEIN KINASE RECEPTOR KEYWDS 2 R4, ACTIVIN RECEPTOR-LIKE KINASE 5, TRANSFERASE-TRANSFERASE KEYWDS 3 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR D.R.DOUGAN,J.D.LAWSON REVDAT 4 06-MAR-24 5USQ 1 REMARK REVDAT 3 22-NOV-17 5USQ 1 REMARK REVDAT 2 26-APR-17 5USQ 1 JRNL REVDAT 1 12-APR-17 5USQ 0 JRNL AUTH M.SABAT,H.WANG,N.SCORAH,J.D.LAWSON,J.ATIENZA,R.KAMRAN, JRNL AUTH 2 M.S.HIXON,D.R.DOUGAN JRNL TITL DESIGN, SYNTHESIS AND OPTIMIZATION OF JRNL TITL 2 7-SUBSTITUTED-PYRAZOLO[4,3-B]PYRIDINE ALK5 (ACTIVIN JRNL TITL 3 RECEPTOR-LIKE KINASE 5) INHIBITORS. JRNL REF BIOORG. MED. CHEM. LETT. V. 27 1955 2017 JRNL REFN ESSN 1464-3405 JRNL PMID 28359790 JRNL DOI 10.1016/J.BMCL.2017.03.026 REMARK 2 REMARK 2 RESOLUTION. 2.55 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0135 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.55 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.35 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 9545 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.182 REMARK 3 R VALUE (WORKING SET) : 0.179 REMARK 3 FREE R VALUE : 0.231 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 482 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.55 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.62 REMARK 3 REFLECTION IN BIN (WORKING SET) : 628 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 89.25 REMARK 3 BIN R VALUE (WORKING SET) : 0.2400 REMARK 3 BIN FREE R VALUE SET COUNT : 36 REMARK 3 BIN FREE R VALUE : 0.2990 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2404 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 31 REMARK 3 SOLVENT ATOMS : 104 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.69 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.47000 REMARK 3 B22 (A**2) : 0.32000 REMARK 3 B33 (A**2) : 1.15000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.310 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.229 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 21.203 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.943 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.904 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2496 ; 0.007 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 2379 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3373 ; 1.194 ; 1.955 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5455 ; 0.892 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 298 ; 5.915 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 116 ;33.048 ;22.931 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 447 ;13.368 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 23 ;13.888 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 365 ; 0.065 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2789 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 592 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 200 A 279 REMARK 3 ORIGIN FOR THE GROUP (A): 12.4328 61.7150 3.3628 REMARK 3 T TENSOR REMARK 3 T11: 0.0168 T22: 0.0323 REMARK 3 T33: 0.0509 T12: -0.0053 REMARK 3 T13: -0.0132 T23: -0.0164 REMARK 3 L TENSOR REMARK 3 L11: 0.0313 L22: 1.0360 REMARK 3 L33: 0.3913 L12: 0.1385 REMARK 3 L13: -0.0606 L23: -0.1364 REMARK 3 S TENSOR REMARK 3 S11: 0.0062 S12: -0.0120 S13: -0.0178 REMARK 3 S21: -0.0306 S22: -0.0221 S23: -0.0133 REMARK 3 S31: 0.0191 S32: 0.0602 S33: 0.0159 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 280 A 498 REMARK 3 ORIGIN FOR THE GROUP (A): 11.3267 83.3885 16.1773 REMARK 3 T TENSOR REMARK 3 T11: 0.0129 T22: 0.0108 REMARK 3 T33: 0.0499 T12: 0.0089 REMARK 3 T13: -0.0123 T23: -0.0208 REMARK 3 L TENSOR REMARK 3 L11: 0.4827 L22: 0.4926 REMARK 3 L33: 0.5002 L12: 0.1601 REMARK 3 L13: 0.2414 L23: 0.3320 REMARK 3 S TENSOR REMARK 3 S11: 0.0181 S12: -0.0297 S13: 0.0955 REMARK 3 S21: -0.0082 S22: -0.0328 S23: 0.0447 REMARK 3 S31: -0.0052 S32: -0.0238 S33: 0.0147 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : WITH TLS ADDED REMARK 4 REMARK 4 5USQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-FEB-17. REMARK 100 THE DEPOSITION ID IS D_1000226350. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-NOV-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.0 -9.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9765 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000, DENZO REMARK 200 DATA SCALING SOFTWARE : HKL-2000, SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10064 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.550 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 4.900 REMARK 200 R MERGE (I) : 0.13700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.55 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 87.6 REMARK 200 DATA REDUNDANCY IN SHELL : 2.90 REMARK 200 R MERGE FOR SHELL (I) : 0.41300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.95 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 16 % PEG 8000 100MM CHES PH 9.2, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.79450 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 45.35600 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.16500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 45.35600 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.79450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 39.16500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 201 -74.64 -127.44 REMARK 500 ARG A 332 -10.32 77.78 REMARK 500 ALA A 361 -71.57 -58.16 REMARK 500 ARG A 372 77.02 64.22 REMARK 500 ASP A 435 76.05 -112.97 REMARK 500 GLN A 497 53.42 -106.30 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8LY A 500 DBREF 5USQ A 200 498 UNP P36897 TGFR1_HUMAN 123 421 SEQRES 1 A 299 THR ILE ALA ARG THR ILE VAL LEU GLN GLU SER ILE GLY SEQRES 2 A 299 LYS GLY ARG PHE GLY GLU VAL TRP ARG GLY LYS TRP ARG SEQRES 3 A 299 GLY GLU GLU VAL ALA VAL LYS ILE PHE SER SER ARG GLU SEQRES 4 A 299 GLU ARG SER TRP PHE ARG GLU ALA GLU ILE TYR GLN THR SEQRES 5 A 299 VAL MET LEU ARG HIS GLU ASN ILE LEU GLY PHE ILE ALA SEQRES 6 A 299 ALA ASP ASN LYS ASP ASN GLY THR TRP THR GLN LEU TRP SEQRES 7 A 299 LEU VAL SER ASP TYR HIS GLU HIS GLY SER LEU PHE ASP SEQRES 8 A 299 TYR LEU ASN ARG TYR THR VAL THR VAL GLU GLY MET ILE SEQRES 9 A 299 LYS LEU ALA LEU SER THR ALA SER GLY LEU ALA HIS LEU SEQRES 10 A 299 HIS MET GLU ILE VAL GLY THR GLN GLY LYS PRO ALA ILE SEQRES 11 A 299 ALA HIS ARG ASP LEU LYS SER LYS ASN ILE LEU VAL LYS SEQRES 12 A 299 LYS ASN GLY THR CYS CYS ILE ALA ASP LEU GLY LEU ALA SEQRES 13 A 299 VAL ARG HIS ASP SER ALA THR ASP THR ILE ASP ILE ALA SEQRES 14 A 299 PRO ASN HIS ARG VAL GLY THR LYS ARG TYR MET ALA PRO SEQRES 15 A 299 GLU VAL LEU ASP ASP SER ILE ASN MET LYS HIS PHE GLU SEQRES 16 A 299 SER PHE LYS ARG ALA ASP ILE TYR ALA MET GLY LEU VAL SEQRES 17 A 299 PHE TRP GLU ILE ALA ARG ARG CYS SER ILE GLY GLY ILE SEQRES 18 A 299 HIS GLU ASP TYR GLN LEU PRO TYR TYR ASP LEU VAL PRO SEQRES 19 A 299 SER ASP PRO SER VAL GLU GLU MET ARG LYS VAL VAL CYS SEQRES 20 A 299 GLU GLN LYS LEU ARG PRO ASN ILE PRO ASN ARG TRP GLN SEQRES 21 A 299 SER CYS GLU ALA LEU ARG VAL MET ALA LYS ILE MET ARG SEQRES 22 A 299 GLU CYS TRP TYR ALA ASN GLY ALA ALA ARG LEU THR ALA SEQRES 23 A 299 LEU ARG ILE LYS LYS THR LEU SER GLN LEU SER GLN GLN HET 8LY A 500 31 HETNAM 8LY N-[2-(5-CHLORO-2-FLUOROPHENYL)PYRIDIN-4-YL]-2- HETNAM 2 8LY [(PIPERIDIN-4-YL)METHYL]-2H-PYRAZOLO[4,3-B]PYRIDIN-7- HETNAM 3 8LY AMINE FORMUL 2 8LY C23 H22 CL F N6 FORMUL 3 HOH *104(H2 O) HELIX 1 AA1 ILE A 201 ARG A 203 5 3 HELIX 2 AA2 SER A 235 ARG A 237 5 3 HELIX 3 AA3 GLU A 238 GLN A 250 1 13 HELIX 4 AA4 SER A 287 TYR A 295 1 9 HELIX 5 AA5 THR A 298 MET A 318 1 21 HELIX 6 AA6 LYS A 335 LYS A 337 5 3 HELIX 7 AA7 THR A 375 MET A 379 5 5 HELIX 8 AA8 ALA A 380 ASP A 385 1 6 HELIX 9 AA9 PHE A 393 ARG A 413 1 21 HELIX 10 AB1 SER A 437 CYS A 446 1 10 HELIX 11 AB2 PRO A 455 SER A 460 5 6 HELIX 12 AB3 CYS A 461 TRP A 475 1 15 HELIX 13 AB4 ASN A 478 ARG A 482 5 5 HELIX 14 AB5 THR A 484 GLN A 497 1 14 SHEET 1 AA1 5 ILE A 205 LYS A 213 0 SHEET 2 AA1 5 GLU A 218 TRP A 224 -1 O ARG A 221 N GLU A 209 SHEET 3 AA1 5 GLU A 227 PHE A 234 -1 O VAL A 229 N GLY A 222 SHEET 4 AA1 5 THR A 274 ASP A 281 -1 O LEU A 278 N LYS A 232 SHEET 5 AA1 5 PHE A 262 ASP A 269 -1 N ASP A 266 O TRP A 277 SHEET 1 AA2 3 ALA A 328 ALA A 330 0 SHEET 2 AA2 3 VAL A 356 ASP A 359 -1 O HIS A 358 N ALA A 328 SHEET 3 AA2 3 THR A 364 ILE A 365 -1 O THR A 364 N ASP A 359 SHEET 1 AA3 2 ILE A 339 VAL A 341 0 SHEET 2 AA3 2 CYS A 347 ILE A 349 -1 O CYS A 348 N LEU A 340 SITE 1 AC1 18 ILE A 211 VAL A 219 ALA A 230 VAL A 231 SITE 2 AC1 18 TYR A 249 LEU A 278 VAL A 279 SER A 280 SITE 3 AC1 18 ASP A 281 TYR A 282 HIS A 283 SER A 287 SITE 4 AC1 18 ASP A 290 THR A 323 LEU A 340 ASP A 351 SITE 5 AC1 18 HOH A 601 HOH A 675 CRYST1 41.589 78.330 90.712 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024045 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012767 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011024 0.00000